Literature DB >> 28688013

A Comprehensive Review of Neutrophilic Diseases.

Angelo V Marzano1,2,3, Alessandro Borghi4, Daniel Wallach5, Massimo Cugno6,7.   

Abstract

Neutrophilic dermatoses are a group of conditions characterized by the accumulation of neutrophils in the skin and clinically presenting with polymorphic cutaneous lesions, including pustules, bullae, abscesses, papules, nodules, plaques and ulcers. In these disorders, the possible involvement of almost any organ system has lead to coin the term 'neutrophilic diseases'. Neutrophilic diseases have close clinicopathological similarities with the autoinflammatory diseases, which present with recurrent episodes of inflammation in the affected organs in the absence of infection, allergy and frank autoimmunity. Neutrophilic diseases may be subdivided into three main groups: (1) deep or hypodermal forms whose paradigm is pyoderma gangrenosum, (2) plaque-type or dermal forms whose prototype is Sweet's syndrome and (3) superficial or epidermal forms among which amicrobial pustulosis of the folds may be considered the model. A forth subset of epidermal/dermal/hypodermal forms has been recently added to the classification of neutrophilic diseases due to the emerging role of the syndromic pyoderma gangrenosum variants, whose pathogenesis has shown a relevant autoinflammatory component. An increasing body of evidence supports the role of pro-inflammatory cytokines like interleukin (IL)-1-beta, IL-17 and tumour necrosis factor (TNF)-alpha in the pathophysiology of neutrophilic diseases similarly to classic monogenic autoinflammatory diseases, suggesting common physiopathological mechanisms. Moreover, mutations of several genes involved in autoinflammatory diseases are likely to play a role in the pathogenesis of neutrophilic diseases, giving rise to regarding them as a spectrum of polygenic autoinflammatory conditions. In this review, we focus on clinical aspects, histopathological features and pathophysiological mechanisms of the paradigmatic forms of neutrophilic diseases, including pyoderma gangrenosum, Sweet's syndrome, amicrobial pustulosis of the folds and the main syndromic presentations of pyoderma gangrenosum. A simple approach for diagnosis and management of these disorders has also been provided.

Entities:  

Keywords:  Amicrobial pustulosis of the folds; Autoinflammation; Neutrophilic diseases; Pyoderma gangrenosum; Sweet’s syndrome

Mesh:

Substances:

Year:  2018        PMID: 28688013     DOI: 10.1007/s12016-017-8621-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  139 in total

Review 1.  Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature.

Authors:  Sinead M Langan; Frank C Powell
Journal:  Int J Dermatol       Date:  2005-08       Impact factor: 2.736

2.  [Amicrobial pustulosis and systemic lupus erythematosus].

Authors:  P Oberlin; M Bagot; M Perrussel; F Leteinturier; J Wechsler; J Revuz
Journal:  Ann Dermatol Venereol       Date:  1991       Impact factor: 0.777

3.  Development of pyoderma gangrenosum during therapy with infliximab.

Authors:  Natalia Jaimes-López; Verónica Molina; Juan E Arroyave; Luz A Vasquez; Ana C Ruiz; Rodrigo Castaño; Mario H Ruiz
Journal:  J Dermatol Case Rep       Date:  2009-08-24

4.  Amicrobial pustulosis of the folds revealing asymptomatic autoimmune thyroiditis.

Authors:  Antoine Claeys; Didier Bessis; Hela Cheikhrouhou; Jean Pouaha; Jean-François Cuny; François Truchetet
Journal:  Eur J Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.328

Review 5.  Pyoderma gangrenosum.

Authors:  J P Callen
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

6.  First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome.

Authors:  S Duchatelet; S Miskinyte; O Join-Lambert; M-N Ungeheuer; C Francès; A Nassif; A Hovnanian
Journal:  Br J Dermatol       Date:  2015-06-11       Impact factor: 9.302

Review 7.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

8.  Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.

Authors:  A V Marzano; M Cugno; V Trevisan; R Lazzari; D Fanoni; E Berti; C Crosti
Journal:  Int J Immunopathol Pharmacol       Date:  2011 Apr-Jun       Impact factor: 3.219

Review 9.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

10.  Sweet's syndrome in children.

Authors:  B W Boatman; R C Taylor; L E Klein; B A Cohen
Journal:  South Med J       Date:  1994-02       Impact factor: 0.954

View more
  27 in total

1.  A sweet fever.

Authors:  Silvia Tiraboschi; Angelo Valerio Marzano; Rosa Lombardi; Giovanni Genovese; Giovanni Boccoli; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  Intern Emerg Med       Date:  2018-11-08       Impact factor: 3.397

Review 2.  A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.

Authors:  Wendy A Pearson; David A Prentice; Deborah L Sinclair; Lee Y Lim; Keryln J Carville
Journal:  Int Wound J       Date:  2019-07-12       Impact factor: 3.315

Review 3.  Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.

Authors:  Vishnu Hosur; Daniel A Skelly; Christopher Francis; Benjamin E Low; Vivek Kohar; Lisa M Burzenski; Mansoor M Amiji; Leonard D Shultz; Michael V Wiles
Journal:  Drug Discov Today       Date:  2020-05-05       Impact factor: 7.851

4.  Inflammasome Regulates Hematopoiesis through Cleavage of the Master Erythroid Transcription Factor GATA1.

Authors:  Sylwia D Tyrkalska; Ana B Pérez-Oliva; Lola Rodríguez-Ruiz; Francisco J Martínez-Morcillo; Francisca Alcaraz-Pérez; Francisco J Martínez-Navarro; Christophe Lachaud; Nouraiz Ahmed; Timm Schroeder; Irene Pardo-Sánchez; Sergio Candel; Azucena López-Muñoz; Avik Choudhuri; Marlies P Rossmann; Leonard I Zon; María L Cayuela; Diana García-Moreno; Victoriano Mulero
Journal:  Immunity       Date:  2019-06-04       Impact factor: 31.745

Review 5.  Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review.

Authors:  Giovanni Genovese; Simona Tavecchio; Emilio Berti; Franco Rongioletti; Angelo Valerio Marzano
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

6.  The great imitator with no diagnostic test: pyoderma gangrenosum.

Authors:  Teresa Alonso-León; Heidi H Hernández-Ramírez; Veronica Fonte-Avalos; Sonia Toussaint-Caire; María E Vega-Memije; Adriana Lozano-Platonoff
Journal:  Int Wound J       Date:  2020-08-11       Impact factor: 3.315

7.  Pathergy testing: prospective comparison of dermatoscopic evaluation and naked eye examination.

Authors:  Aysegul Sevim Kecici; Zekayi Kutlubay; Server Serdaroglu; Yalcin Tuzun
Journal:  Intern Emerg Med       Date:  2019-02-08       Impact factor: 3.397

8.  Sweet's Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report.

Authors:  Simar Berro; Albane Calas; Pierre Sohier; Delphine Darbord; Nicolas Dupin
Journal:  Acta Derm Venereol       Date:  2021-06-30       Impact factor: 3.875

Review 9.  Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Authors:  Quindelyn S Cook; Carlton J Zdanski; Craig N Burkhart; Paul B Googe; Patrick Thompson; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2019-05-14       Impact factor: 4.919

10.  Malignancy-associated Sweet syndrome presenting with simultaneous histopathologic and morphologic variants.

Authors:  Nathan Burke; Sami K Saikaly; Kiran Motaparthi; Nicole R Bender
Journal:  JAAD Case Rep       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.